Estadisticas : CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations

Felip, E.
Visitas:184
100 ( Estados Unidos de América )
38 ( Hong kong )
14 ( Singapur )
8 ( Reino Unido )
6 ( Letonia )
4 ( Finlandia )
3 ( Canadá )
3 ( Brasil )
2 ( Alemania )
2 ( Vietnam )
1 ( Bélgica )
1 ( Sudáfrica )
1 ( Arabia Saudita )
1 ( España )

Descargas: 120